
Will TrumpRx actually lower drug prices?
On Point with Meghna Chakrabarti
00:00
Should Prices Reflect Value Rather Than R&D Costs?
Meghna asks about pricing rationale; Emond argues for cost-effectiveness approaches and targeted incentives for high-value drugs.
Transcript
Play full episode


